In This Article:
-
Revenue: $18.3 million, a 142% increase compared to $7.6 million in Q3 last year.
-
Gross Margin: 42.7%, compared to 42.5% in the same period last year.
-
Net Income: Non-GAAP net income of $2.0 million or $0.07 per diluted share, compared to a non-GAAP net loss of $888,000 or negative $0.03 per diluted share in Q3 fiscal 2024.
-
Bookings: $24.1 million in the third quarter of fiscal 2025.
-
Backlog: $18.2 million at the end of the quarter, with an effective backlog of $21.8 million after additional bookings.
-
Cash and Cash Equivalents: $31.4 million at the end of Q3, down from $35.2 million at the end of Q2.
-
Operating Expenses: Non-GAAP operating expenses were $6.3 million, a 34% increase from $4.7 million in Q3 last year.
-
Interest Income: $270,000 earned in the third quarter.
Release Date: April 08, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
-
Aehr Test Systems (NASDAQ:AEHR) reported significant revenue growth, exceeding analyst expectations for both revenue and bottom line for the third quarter.
-
The company has successfully diversified its revenue streams, reducing reliance on silicon carbide, which accounted for over 90% of business in fiscal 2024, to less than 40% this year.
-
Aehr Test Systems (NASDAQ:AEHR) has expanded into high-growth markets such as AI processors, gallium nitride semiconductors, and hard disk drive components.
-
The company has made significant progress in developing new products, including the world's first wafer-level burn-in systems specifically designed for AI processors.
-
Aehr Test Systems (NASDAQ:AEHR) has a robust supply chain strategy to mitigate potential impacts from tariffs, including redirecting materials and utilizing international locations for assembly and testing.
Negative Points
-
The company is facing uncertainty due to recent U.S. tariff announcements, which could lead to potential delays or pauses in customer orders and supply chain disruptions.
-
Aehr Test Systems (NASDAQ:AEHR) has temporarily withdrawn its guidance for the current fiscal year due to the uncertainty surrounding tariffs and their secondary effects.
-
The company experienced a lower-than-expected gross margin due to onetime charges related to inventory accounting adjustments and high manufacturing overhead.
-
There are concerns about potential legal expenses in upcoming quarters as Aehr Test Systems (NASDAQ:AEHR) seeks to protect its intellectual property rights in China and defend against class action and derivative complaints in the U.S.
-
The integration of the InCal acquisition is ongoing, with plans to shut down the InCal facility by the first quarter of fiscal 2026, which may involve additional costs and operational adjustments.